omega-n-methylarginine has been researched along with Coronary Artery Disease in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (30.00) | 18.2507 |
| 2000's | 16 (53.33) | 29.6817 |
| 2010's | 5 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beltrame, JF; Carbone, A; Copus, B; Leong, DP; Liew, GY; Nelson, AJ; Nicholls, SJ; Puri, R; Wong, DT; Worthley, MI; Worthley, SG | 1 |
| Badimon, L; Casani, L; Estruch, R; Lamuela-Raventos, RM; Mendieta, G; Vilahur, G | 1 |
| Gerstenblith, G; Hays, AG; Iantorno, M; Schär, M; Soleimanifard, S; Steinberg, A; Stuber, M; Weiss, RG | 1 |
| Chayama, K; Fujii, Y; Fujimura, N; Goto, C; Hata, T; Hidaka, T; Higashi, Y; Idei, N; Kihara, Y; Nakamura, S; Soga, J; Taguchi, A | 1 |
| Brennan, DM; Cho, L; Hazen, SL; Tang, WH; Wang, Z | 1 |
| Cannon, RO | 1 |
| Lennon, R; Lerman, A; Lerman, LO; Mathew, V; Nelson, RE; Prasad, A; Pumper, GM; Raichlin, E; Reriani, M; Rihal, C | 1 |
| Al-Hesayen, A; Gori, T; Miner, SE; Nield, LE; Parker, JD | 1 |
| Collins, P; Hayward, CS; Kraidly, M; Webb, CM | 1 |
| Drexler, H; Hornig, B; Kohler, C; Schlink, D; Tatge, H | 1 |
| Heitzer, T; Köke, K; Meinertz, T; Munzel, T; Ollmann, I | 1 |
| Chan, NN; Colhoun, HM; Fuller, JH; Rubens, M | 1 |
| Fujioka, D; Kawabata, K; Kugiyama, K; Nakamura, S; Ogawa, H; Sugiyama, S | 1 |
| Breuer, S; Busse, R; Dimmeler, S; Fichtlscherer, S; Fleming, I; Zeiher, AM | 1 |
| Barbato, E; Bartunek, J; Chiariello, M; Cirillo, P; De Bruyne, B; De Luca, G; Galasso, G; Iaccarino, G; Piscione, F; Wijns, W | 1 |
| Anderson, TJ; Curtis, MJ; Goodhart, DM; Worthley, MI | 1 |
| Al-Shaer, MH; Barenz, TA; Choueiri, NE; Correia, ML; Haynes, WG; Sinkey, CA | 1 |
| Baldus, S; Böger, R; Heitzer, T; Karstens, M; Meinertz, T; Ortak, M; Rudolph, V; Schwedhelm, E; Sydow, K; Tschentscher, P | 1 |
| Andrews, NP; Cannon, RO; Dakak, N; Gilligan, DM; Panza, JA; Quyyumi, AA | 1 |
| Nishikawa, Y; Ogawa, S | 1 |
| Andrews, NP; Cannon, RO; Dakak, N; Husain, S; Mulcahy, D; Panza, JA; Quyyumi, AA | 1 |
| Crake, T; Davies, GJ; Lefroy, DC; Tentolouris, C; Tousoulis, D; Toutouzas, P | 1 |
| Crake, T; Davies, G; Tentolouris, C; Tousoulis, D; Toutouzas, P | 1 |
| Anderson, TJ; Goodhart, DM | 1 |
| Crake, T; Davies, GJ; Katsimaglis, G; Stefanadis, C; Tentolouris, C; Tousoulis, D; Toutouzas, P | 1 |
| Husain, S; Prasad, A; Quyyumi, AA | 1 |
| Baumgart, D; Bruck, H; Erbel, R; Oldenburg, O; Philipp, T; Wenzel, RR | 1 |
| Epstein, N; Narayanan, S; Prasad, A; Quyyumi, AA; Waclawiw, MA | 1 |
| Davies, G; Goumas, G; Stefanadis, C; Tentolouris, C; Tousoulis, D; Toutouzas, P; Trikas, A | 1 |
| Egashira, K; Eshima, K; Hironaga, K; Hirooka, Y; Masumoto, A; Setoguchi, S; Takeshita, A | 1 |
2 review(s) available for omega-n-methylarginine and Coronary Artery Disease
| Article | Year |
|---|---|
Microvascular angina and the continuing dilemma of chest pain with normal coronary angiograms.
Topics: Adult; Animals; Chest Pain; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Endothelium, Vascular; Female; Humans; Microcirculation; Microvascular Angina; Middle Aged; Myocardial Ischemia; Nitric Oxide; omega-N-Methylarginine; Risk Factors; Ventricular Function, Left | 2009 |
Skin microcirculation in healthy subjects and patients with arteriosclerosis.
Topics: Arteriosclerosis; Coronary Artery Disease; Endothelium, Vascular; Humans; Microcirculation; Nitric Oxide Synthase; omega-N-Methylarginine; Predictive Value of Tests; Skin; Vascular Resistance | 1999 |
12 trial(s) available for omega-n-methylarginine and Coronary Artery Disease
| Article | Year |
|---|---|
Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis.
Topics: Adult; Atrasentan; Blood Glucose; Blood Pressure; Coronary Artery Disease; Coronary Circulation; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Female; Follow-Up Studies; Heart Rate; Humans; Kidney; Lipoprotein(a); Male; Microcirculation; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Pyrrolidines; Receptor, Endothelin A; Triglycerides; Uric Acid | 2010 |
Assessment of endothelial function using peripheral waveform analysis: a clinical application.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Blood Pressure; Body Mass Index; Coronary Artery Disease; Endothelium, Vascular; Heart Rate; Humans; Male; Manometry; Nitric Oxide Synthase; Nitroglycerin; omega-N-Methylarginine; Radial Artery; Reference Values; Reproducibility of Results; Vasodilator Agents | 2002 |
AT1-receptor antagonism improves endothelial function in coronary artery disease by a bradykinin/B2-receptor-dependent mechanism.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Flow Velocity; Bradykinin; Bradykinin Receptor Antagonists; Coronary Artery Disease; Endothelium, Vascular; Enzyme Inhibitors; Humans; Infusions, Intra-Arterial; Middle Aged; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Radial Artery; Receptor, Angiotensin, Type 1; Receptor, Bradykinin B2; Receptors, Bradykinin; Tetrazoles | 2003 |
Platelet glycoprotein IIb/IIIa receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease.
Topics: Acetylcholine; Biological Availability; Blood Flow Velocity; Blood Platelets; Coronary Artery Disease; Endothelium, Vascular; Enzyme Inhibitors; Eptifibatide; Forearm; Humans; Male; Middle Aged; Nitric Oxide; Nitric Oxide Donors; omega-N-Methylarginine; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Plethysmography; Tirofiban; Tyrosine; Vasodilation; Vasodilator Agents; Vasomotor System | 2003 |
Polymorphism in glutamate-cysteine ligase modifier subunit gene is associated with impairment of nitric oxide-mediated coronary vasomotor function.
Topics: 5' Flanking Region; Acetylcholine; Blood Flow Velocity; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Enzyme Inhibitors; Genetic Predisposition to Disease; Genetic Testing; Glutamate-Cysteine Ligase; Humans; Japan; Multivariate Analysis; Nitric Oxide; omega-N-Methylarginine; Polymorphism, Genetic; Protein Subunits; Risk Factors; Vascular Patency; Vasodilator Agents; Vasomotor System | 2003 |
Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease.
Topics: Acetylcholine; Adult; Aryl Hydrocarbon Hydroxylases; Ascorbic Acid; Blood Proteins; Coronary Artery Disease; Cytochrome P-450 CYP2C9; Endothelium, Vascular; Enzyme Inhibitors; Forearm; Humans; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Oxidation-Reduction; Regional Blood Flow; Sulfaphenazole; Vasodilation; Vasodilator Agents | 2004 |
Effects of aging and atherosclerosis on endothelial and vascular smooth muscle function in humans.
Topics: Acetylcholine; Adult; Age Factors; Aged; Aged, 80 and over; Aging; Coronary Artery Disease; Cross-Over Studies; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Humans; Male; Middle Aged; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow; Vasoconstriction; Vasodilation; Vasodilator Agents | 2006 |
Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects.
Topics: Acetylcholine; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspirin; Biological Availability; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Endothelium, Vascular; Enzyme Inhibitors; Humans; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Ticlopidine; Vasodilation; Vasodilator Agents | 2006 |
Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
Topics: Acetylcholine; Adenosine; Adult; Arginine; Cardiac Pacing, Artificial; Coronary Artery Disease; Coronary Circulation; Female; Humans; Male; Middle Aged; Myocardium; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Risk Factors; Vascular Resistance; Vasodilation | 1995 |
Effect of enalaprilat on nitric oxide activity in coronary artery disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Disease; Enalaprilat; Endothelium, Vascular; Enzyme Inhibitors; Female; Femoral Artery; Humans; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Reproducibility of Results; Vascular Resistance; Vasodilation | 1999 |
The impact of risk factors for atherosclerosis on the vasomotor effects of inhibition of nitric oxide synthesis in patients with normal angiograms.
Topics: Aged; Analysis of Variance; Coronary Angiography; Coronary Artery Disease; Endothelium, Vascular; Female; Humans; Hypercholesterolemia; Hypertension; Infusions, Intra-Arterial; Linear Models; Male; Middle Aged; Nitric Oxide; Nitroglycerin; omega-N-Methylarginine; Reference Values; Risk Factors; Smoking; Vasoconstriction; Vasodilation | 2000 |
Effect of pravastatin on endothelial function in patients with coronary artery disease (cholesterol-independent effect of pravastatin).
Topics: Acetylcholine; Anticholesteremic Agents; Cholesterol; Coronary Artery Disease; Endothelium, Vascular; Forearm; Humans; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Pravastatin; Vasodilation; Vasodilator Agents | 2001 |
16 other study(ies) available for omega-n-methylarginine and Coronary Artery Disease
| Article | Year |
|---|---|
Coronary artery wall shear stress is associated with endothelial dysfunction and expansive arterial remodelling in patients with coronary artery disease.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Coronary Vessels; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; omega-N-Methylarginine; Severity of Illness Index; Shear Strength; Ultrasonography, Doppler; Ultrasonography, Interventional; Vascular Remodeling; Vasodilation | 2015 |
Beer elicits vasculoprotective effects through Akt/eNOS activation.
Topics: Acetylcholine; Alanine; Animals; Beer; Cholesterol; Coronary Artery Disease; Coronary Vessels; Diet, Western; Dyslipidemias; Endothelium, Vascular; Enzyme Inhibitors; Ethanol; Female; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Oncogene Protein v-akt; Oxidative Stress; Random Allocation; Sus scrofa; Swine; Triglycerides; Vasodilation; Vasodilator Agents | 2014 |
Coronary vasomotor responses to isometric handgrip exercise are primarily mediated by nitric oxide: a noninvasive MRI test of coronary endothelial function.
Topics: Adult; Aged; Case-Control Studies; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Endothelium, Vascular; Enzyme Inhibitors; Exercise; Female; Hand Strength; Heart Function Tests; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Vasoconstriction; Vasodilation | 2015 |
Oral infection-inflammatory pathway, periodontitis, is a risk factor for endothelial dysfunction in patients with coronary artery disease.
Topics: Acetylcholine; Aged; C-Reactive Protein; Coronary Artery Disease; Endothelium, Vascular; Female; Forearm; Humans; Interleukin-6; Male; Middle Aged; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Periodontitis; Regional Blood Flow; Vasodilation | 2009 |
Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition.
Topics: Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Citrulline; Coronary Artery Disease; Creatinine; Female; Humans; Lysine; Male; Metabolomics; Methylation; Middle Aged; Nitric Oxide Synthase; Odds Ratio; omega-N-Methylarginine; Ornithine; Prognosis; Prospective Studies; Protein Processing, Post-Translational; Risk Assessment; Risk Factors; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Time Factors | 2009 |
Acetylcholine acutely modifies nitric oxide synthase function in the human coronary circulation.
Topics: Acetylcholine; Aged; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Creatinine; Diabetes Mellitus; Female; Humans; Hypertension; Male; Middle Aged; Nitric Oxide Synthase; omega-N-Methylarginine; Oxygen; Vasodilation; Vasomotor System | 2010 |
Von Willebrand factor in type 1 diabetes: its production and coronary artery calcification.
Topics: Adult; Albuminuria; Area Under Curve; Bradykinin; Calcinosis; Coronary Artery Disease; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Male; Nitric Oxide; Nitroglycerin; omega-N-Methylarginine; Risk Factors; Statistics as Topic; Vasodilator Agents; von Willebrand Factor | 2003 |
Role of beta2 adrenergic receptors in human atherosclerotic coronary arteries.
Topics: Acetylcholine; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Albuterol; Constriction, Pathologic; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Endothelium, Vascular; Female; Hemodynamics; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nitric Oxide Synthase; Nitro Compounds; omega-N-Methylarginine; Phentolamine; Receptors, Adrenergic, beta-2; Vasoconstrictor Agents; Vasodilator Agents | 2005 |
Relation of Basal coronary nitric oxide activity to the burden of atherosclerosis.
Topics: Adenosine; Blood Flow Velocity; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Enzyme Inhibitors; Female; Humans; Laser-Doppler Flowmetry; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Nitroglycerin; omega-N-Methylarginine; Pulsatile Flow; Severity of Illness Index; Ultrasonography | 2005 |
Importance of nitric oxide in the coronary artery at rest and during pacing in humans.
Topics: Blood Flow Velocity; Cardiac Catheterization; Cardiac Pacing, Artificial; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Vasodilation | 1997 |
Nitric oxide activity in the atherosclerotic human coronary circulation.
Topics: Acetylcholine; Age Factors; Aged; Coronary Artery Disease; Coronary Vessels; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Regional Blood Flow; Sex Factors; Vascular Resistance; Vasodilation | 1997 |
Effects of inhibition of nitric oxide synthesis in patients with coronary artery disease and stable angina.
Topics: Angina Pectoris; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Dose-Response Relationship, Drug; Electrocardiography; Enzyme Inhibitors; Humans; Nitric Oxide; Nitric Oxide Synthase; Nitroglycerin; omega-N-Methylarginine; Vasoconstriction | 1997 |
Basal and flow-mediated nitric oxide production by atheromatous coronary arteries.
Topics: Blood Flow Velocity; Cardiac Pacing, Artificial; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Coronary Disease; Enzyme Inhibitors; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Sodium Chloride; Ultrasonography, Doppler; Vasodilation | 1997 |
Role of nitric oxide in coronary arterial vasomotion and the influence of coronary atherosclerosis and its risks.
Topics: Adult; Cardiac Pacing, Artificial; Coronary Artery Disease; Coronary Vessels; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Male; Microcirculation; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Risk Factors; Vasodilation | 1998 |
Effects of changing the availability of the substrate for nitric oxide synthase by L-arginine administration on coronary vasomotor tone in angina patients with angiographically narrowed and in patients with normal coronary arteries.
Topics: Aged; Angina Pectoris; Arginine; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Nitric Oxide Synthase; Nitroglycerin; omega-N-Methylarginine; Substance P; Vasoconstriction | 1998 |
The insertion/deletion polymorphism of the angiotensin-converting enzyme gene determines coronary vascular tone and nitric oxide activity.
Topics: Acetylcholine; Coronary Artery Disease; Coronary Vessels; Gene Deletion; Genotype; Humans; Middle Aged; Muscle Tonus; Muscle, Smooth, Vascular; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Vasodilator Agents | 2000 |